Angelfish Inv. PLC – Extension of Reporting Deadline

clock Jul 01,2021
rns


Angelfish Inv. PLC – Extension of Reporting Deadline




RNS Number : 8557D
Angelfish Investments PLC
01 July 2021
 

1 July 2021

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE (“RIS”), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Angelfish Investments plc

(To be renamed 1graine plc)

(“Company”)

 

 

Extension of Reporting Deadline

  

The Company announces that, due to logistical issues arising from Covid – 19 restrictions and in accordance with the Stakeholder Update released by the Aquis Stock Exchange on 31 March 2020, the Company has been granted an extension of one month for the publication of its annual Report and Accounts for the year ended 31 December 2020. The Company will publish these results as soon as possible, and by no later than the end of July 2021. 

 

The Company also notes, inter alia, as post balance sheet events, the recapitalisation of the Company, that has lead to restructuring, an equity financing of £2,000,500 gross and board changes, that completed on 28 June 2021. Production of the audited accounts are advanced and are expected to be produced within the above mentioned reporting deadline.

 

The Directors of the Company, who have issued this RIS announcement after due and careful enquiry, accept responsibility for its content.

 

Enquiries

Company :

Simon Grant-Rennick (Director)
Burns Singh Tennent-Bhohi (Director)               
Office Line: +44 (0) 20 3778 0755

 

AQSE Growth Market Corporate Adviser

 

Peterhouse Capital Limited

Guy Miller / Mark Anwyl

Tel: +44 (0) 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

MSCEAEXFEFKFEFA
]]>

View article on Aquis

Create your account